COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

A Fendler, EGE de Vries… - Nature Reviews …, 2022 - nature.com
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

C Cordonnier, S Einarsdottir, S Cesaro… - The Lancet infectious …, 2019 - thelancet.com
Infection is a main concern after haemopoietic stem cell transplantation (HSCT) and a major
cause of transplant-related mortality. Some of these infections are preventable by …

ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease

T Kucharzik, P Ellul, T Greuter, JF Rahier… - Journal of Crohn's …, 2021 - academic.oup.com
The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial

A Bastidas, J De La Serna, M El Idrissi, L Oostvogels… - Jama, 2019 - jamanetwork.com
Importance Herpes zoster, a frequent complication following autologous hematopoietic stem
cell transplantation (HSCT), is associated with significant morbidity. A nonlive adjuvanted …

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post …

AF Dagnew, O Ilhan, WS Lee, D Woszczyk… - The Lancet infectious …, 2019 - thelancet.com
Background The adjuvanted recombinant zoster vaccine (Shingrix) can prevent herpes
zoster in older adults and autologous haemopoietic stem cell transplant recipients. We …

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

H Ludwig, M Boccadoro, P Moreau, J San-Miguel… - Leukemia, 2021 - nature.com
Vaccination is one of the most successful medical interventions that has saved the life of
millions of people. Vaccination is particularly important in patients with multiple myeloma …

Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation

KM Krueger, MG Ison, C Ghossein - American Journal of Kidney Diseases, 2020 - Elsevier
Infection is a major cause of morbidity and mortality in patients with chronic kidney disease
(CKD), including those receiving maintenance dialysis or with a kidney transplant. Although …

Toward precision adjuvants: optimizing science and safety

E Nanishi, DJ Dowling, O Levy - Current opinion in pediatrics, 2020 - journals.lww.com
Toward precision adjuvants: optimizing science and safety : Current Opinion in Pediatrics
Toward precision adjuvants: optimizing science and safety : Current Opinion in Pediatrics Log …

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in …

M Mikulska, S Cesaro, H de Lavallade… - The Lancet Infectious …, 2019 - thelancet.com
Patients with haematological malignancies are at high risk of infection because of various
mechanisms of humoral and cell-mediated immune deficiencies, which mainly depend on …

[PDF][PDF] Herpes zoster risk in immunocompromised adults in the United States: a systematic review

SL McKay, A Guo, SA Pergam… - Clinical Infectious …, 2020 - academic.oup.com
Background The primary reported risk factors for herpes zoster (HZ) include increasing age
and immunodeficiency, yet estimates of HZ risk by immunocompromising condition have not …